Inflammation and post‐traumatic stress disorder

While post‐traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Psychiatry and clinical neurosciences Ročník 73; číslo 4; s. 143 - 153
Hlavní autoři: Hori, Hiroaki, Kim, Yoshiharu
Médium: Journal Article
Jazyk:angličtina
Vydáno: Melbourne John Wiley & Sons Australia, Ltd 01.04.2019
Wiley Subscription Services, Inc
Témata:
Arteriosclerosis
Autoimmune diseases
Biomarkers
Cardiovascular diseases
cytokine
Cytokines
Epidemiology
Inflammation
Metabolic syndrome
neuroinflammation
Pathogenesis
Pathophysiology
Post traumatic stress disorder
treatment
ISSN:1323-1316, 1440-1819, 1440-1819
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract While post‐traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated that PTSD is associated with significantly increased rates of physical comorbidities in which immune dysregulation is involved, such as metabolic syndrome, atherosclerotic cardiovascular disease, and autoimmune diseases. In line with this, a number of blood biomarker studies have reported that compared to healthy controls, individuals with PTSD exhibit significantly elevated levels of proinflammatory markers, such as interleukin‐1β, interleukin‐6, tumor necrosis factor‐α, and C‐reactive protein. Moreover, various lines of animal and human research have suggested that inflammation is not only associated with PTSD but also can play an important role in its pathogenesis and pathophysiology. In this review, we first summarize evidence suggestive of increased inflammation in PTSD. We then examine findings that suggest possible mechanisms of inflammation in this disorder in terms of two different but interrelated perspectives: putative causes of increased proinflammatory activities and potential consequences that inflammation generates. Given that there is currently a dearth of treatment options for PTSD, possibilities of new therapeutic approaches using pharmacological and non‐pharmacological treatments/interventions that have anti‐inflammatory effects are also discussed. Despite the increasing attention given to the inflammatory pathology of PTSD, there remains much to be elucidated, including more detailed mechanisms of inflammation, potential usefulness of inflammatory biomarkers as diagnostic and prognostic markers, and efficacy of novel treatment strategies targeting inflammation.
AbstractList While post‐traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated that PTSD is associated with significantly increased rates of physical comorbidities in which immune dysregulation is involved, such as metabolic syndrome, atherosclerotic cardiovascular disease, and autoimmune diseases. In line with this, a number of blood biomarker studies have reported that compared to healthy controls, individuals with PTSD exhibit significantly elevated levels of proinflammatory markers, such as interleukin‐1β, interleukin‐6, tumor necrosis factor‐α, and C‐reactive protein. Moreover, various lines of animal and human research have suggested that inflammation is not only associated with PTSD but also can play an important role in its pathogenesis and pathophysiology. In this review, we first summarize evidence suggestive of increased inflammation in PTSD. We then examine findings that suggest possible mechanisms of inflammation in this disorder in terms of two different but interrelated perspectives: putative causes of increased proinflammatory activities and potential consequences that inflammation generates. Given that there is currently a dearth of treatment options for PTSD, possibilities of new therapeutic approaches using pharmacological and non‐pharmacological treatments/interventions that have anti‐inflammatory effects are also discussed. Despite the increasing attention given to the inflammatory pathology of PTSD, there remains much to be elucidated, including more detailed mechanisms of inflammation, potential usefulness of inflammatory biomarkers as diagnostic and prognostic markers, and efficacy of novel treatment strategies targeting inflammation.
While post‐traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated that PTSD is associated with significantly increased rates of physical comorbidities in which immune dysregulation is involved, such as metabolic syndrome, atherosclerotic cardiovascular disease, and autoimmune diseases. In line with this, a number of blood biomarker studies have reported that compared to healthy controls, individuals with PTSD exhibit significantly elevated levels of proinflammatory markers, such as interleukin‐1β, interleukin‐6, tumor necrosis factor‐α, and C‐reactive protein. Moreover, various lines of animal and human research have suggested that inflammation is not only associated with PTSD but also can play an important role in its pathogenesis and pathophysiology. In this review, we first summarize evidence suggestive of increased inflammation in PTSD. We then examine findings that suggest possible mechanisms of inflammation in this disorder in terms of two different but interrelated perspectives: putative causes of increased proinflammatory activities and potential consequences that inflammation generates. Given that there is currently a dearth of treatment options for PTSD, possibilities of new therapeutic approaches using pharmacological and non‐pharmacological treatments/interventions that have anti‐inflammatory effects are also discussed. Despite the increasing attention given to the inflammatory pathology of PTSD, there remains much to be elucidated, including more detailed mechanisms of inflammation, potential usefulness of inflammatory biomarkers as diagnostic and prognostic markers, and efficacy of novel treatment strategies targeting inflammation.
While post-traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated that PTSD is associated with significantly increased rates of physical comorbidities in which immune dysregulation is involved, such as metabolic syndrome, atherosclerotic cardiovascular disease, and autoimmune diseases. In line with this, a number of blood biomarker studies have reported that compared to healthy controls, individuals with PTSD exhibit significantly elevated levels of proinflammatory markers, such as interleukin-1β, interleukin-6, tumor necrosis factor-α, and C-reactive protein. Moreover, various lines of animal and human research have suggested that inflammation is not only associated with PTSD but also can play an important role in its pathogenesis and pathophysiology. In this review, we first summarize evidence suggestive of increased inflammation in PTSD. We then examine findings that suggest possible mechanisms of inflammation in this disorder in terms of two different but interrelated perspectives: putative causes of increased proinflammatory activities and potential consequences that inflammation generates. Given that there is currently a dearth of treatment options for PTSD, possibilities of new therapeutic approaches using pharmacological and non-pharmacological treatments/interventions that have anti-inflammatory effects are also discussed. Despite the increasing attention given to the inflammatory pathology of PTSD, there remains much to be elucidated, including more detailed mechanisms of inflammation, potential usefulness of inflammatory biomarkers as diagnostic and prognostic markers, and efficacy of novel treatment strategies targeting inflammation.While post-traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence has highlighted a link between this disorder and alterations in the immune and inflammatory systems. Epidemiological studies have demonstrated that PTSD is associated with significantly increased rates of physical comorbidities in which immune dysregulation is involved, such as metabolic syndrome, atherosclerotic cardiovascular disease, and autoimmune diseases. In line with this, a number of blood biomarker studies have reported that compared to healthy controls, individuals with PTSD exhibit significantly elevated levels of proinflammatory markers, such as interleukin-1β, interleukin-6, tumor necrosis factor-α, and C-reactive protein. Moreover, various lines of animal and human research have suggested that inflammation is not only associated with PTSD but also can play an important role in its pathogenesis and pathophysiology. In this review, we first summarize evidence suggestive of increased inflammation in PTSD. We then examine findings that suggest possible mechanisms of inflammation in this disorder in terms of two different but interrelated perspectives: putative causes of increased proinflammatory activities and potential consequences that inflammation generates. Given that there is currently a dearth of treatment options for PTSD, possibilities of new therapeutic approaches using pharmacological and non-pharmacological treatments/interventions that have anti-inflammatory effects are also discussed. Despite the increasing attention given to the inflammatory pathology of PTSD, there remains much to be elucidated, including more detailed mechanisms of inflammation, potential usefulness of inflammatory biomarkers as diagnostic and prognostic markers, and efficacy of novel treatment strategies targeting inflammation.
Author Kim, Yoshiharu
Hori, Hiroaki
Author_xml – sequence: 1
  givenname: Hiroaki
  orcidid: 0000-0002-4548-7110
  surname: Hori
  fullname: Hori, Hiroaki
  email: hori@ncnp.go.jp
  organization: National Institute of Mental Health, National Center of Neurology and Psychiatry
– sequence: 2
  givenname: Yoshiharu
  surname: Kim
  fullname: Kim, Yoshiharu
  organization: National Institute of Mental Health, National Center of Neurology and Psychiatry
BookMark eNp1kE1OwzAQhS1UJEphwQ0isYFFWo_tJM4SVfxUqoBF95ZrO1KqxA52ItQdR-CMnAT3Z1XBbGY0-t5o3rtEI-usQegG8BRizTplp0A4wWdoDIzhFDiUozhTQlOgkF-gyxA2GGNKcxgjWNiqkW0r-9rZRFqddC70P1_fvZfDbquS0HsTQqLr4Lw2_gqdV7IJ5vrYJ2j19Liav6TLt-fF_GGZKpZRnJLCrBnoShLFFae6zNa5KXJNS0O4JhUrMGaEAjc0M-sKV5hlihKSaVMwndMJujuc7bz7GEzoRVsHZZpGWuOGIAgUJQOC-Q69PUE3bvA2PicIwRkwTqPbCZodKOVdCN5UQtX93na0WjcCsNglKGKCYp9gVNyfKDpft9Jv_2SP1z_rxmz_B8X7_PWg-AUVb4FJ
CitedBy_id crossref_primary_10_3390_biomedicines10050953
crossref_primary_10_1016_j_intimp_2023_110745
crossref_primary_10_1038_s41398_022_02230_3
crossref_primary_10_12998_wjcc_v12_i14_2359
crossref_primary_10_1016_j_genhosppsych_2021_12_003
crossref_primary_10_1016_j_phrs_2021_105581
crossref_primary_10_17816_rjpbr676795
crossref_primary_10_1002_advs_202411339
crossref_primary_10_1007_s10286_024_01014_7
crossref_primary_10_1038_s41598_019_54508_0
crossref_primary_10_3390_ijms25115905
crossref_primary_10_1016_j_concog_2024_103731
crossref_primary_10_1016_j_bbi_2023_09_005
crossref_primary_10_1016_j_bbi_2023_09_004
crossref_primary_10_1186_s12974_020_02064_0
crossref_primary_10_1016_j_bbi_2023_02_015
crossref_primary_10_1016_j_bpsgos_2023_08_001
crossref_primary_10_1016_j_neuint_2020_104921
crossref_primary_10_1136_bmjopen_2024_093467
crossref_primary_10_1016_j_pharmthera_2022_108212
crossref_primary_10_1089_jir_2019_0236
crossref_primary_10_1016_j_it_2022_12_003
crossref_primary_10_3390_antiox9020107
crossref_primary_10_1002_jts_22994
crossref_primary_10_1038_s41380_022_01488_9
crossref_primary_10_1177_20503121231160953
crossref_primary_10_1503_jpn_190021
crossref_primary_10_3390_jpm12071067
crossref_primary_10_1016_j_freeradbiomed_2025_02_034
crossref_primary_10_3390_brainsci13091283
crossref_primary_10_3389_fimmu_2021_760322
crossref_primary_10_3389_fpsyt_2023_1240783
crossref_primary_10_3390_ijms241612564
crossref_primary_10_1371_journal_pone_0281125
crossref_primary_10_1016_j_etap_2021_103611
crossref_primary_10_1055_s_0042_1750013
crossref_primary_10_1016_j_cpr_2022_102177
crossref_primary_10_1038_s41398_022_02094_7
crossref_primary_10_1111_jnc_15439
crossref_primary_10_1002_jts_22619
crossref_primary_10_1016_j_cca_2024_120093
crossref_primary_10_3389_fnbeh_2023_1112837
crossref_primary_10_3390_ijerph20216976
crossref_primary_10_1016_j_bbi_2025_106104
crossref_primary_10_1152_japplphysiol_00694_2019
crossref_primary_10_3390_jcm9092951
crossref_primary_10_1097_INF_0000000000004162
crossref_primary_10_1111_acps_13520
crossref_primary_10_3390_biomedicines10081929
crossref_primary_10_1016_j_neulet_2024_138074
crossref_primary_10_1007_s11481_023_10064_z
crossref_primary_10_1016_j_cbi_2022_110296
crossref_primary_10_3389_fimmu_2021_631881
crossref_primary_10_3390_cells11132034
crossref_primary_10_3390_genes13050843
crossref_primary_10_1016_j_jep_2024_118425
crossref_primary_10_1007_s11102_024_01434_8
crossref_primary_10_1007_s43032_024_01486_y
crossref_primary_10_1016_j_bbr_2024_114942
crossref_primary_10_1016_j_brainresbull_2023_02_013
crossref_primary_10_1038_s41380_023_02278_7
crossref_primary_10_1093_aje_kwac104
crossref_primary_10_1016_j_biopsych_2019_11_005
crossref_primary_10_1093_ibd_izab152
crossref_primary_10_1016_j_intimp_2024_113763
crossref_primary_10_5847_wjem_j_1920_8642_2024_013
crossref_primary_10_3389_fphys_2021_649554
crossref_primary_10_1038_s41598_020_78410_2
crossref_primary_10_21272_eumj_2025_13_2__364_372
crossref_primary_10_1186_s12888_025_06886_1
crossref_primary_10_3138_jmvfh_2019_0036
crossref_primary_10_1016_j_jpsychores_2022_110938
crossref_primary_10_1016_j_janxdis_2022_102543
crossref_primary_10_1016_j_ejtd_2025_100510
crossref_primary_10_3390_brainsci12010102
crossref_primary_10_1093_milmed_usac095
crossref_primary_10_3390_biom14111384
crossref_primary_10_1007_s12035_023_03312_z
crossref_primary_10_1097_NMD_0000000000001360
crossref_primary_10_3389_fphys_2023_1341204
crossref_primary_10_1097_JXX_0000000000000864
crossref_primary_10_1155_2022_1384609
crossref_primary_10_1016_j_yfrne_2022_100994
crossref_primary_10_1007_s12671_022_01969_6
crossref_primary_10_3389_fpsyt_2020_571636
crossref_primary_10_3389_fpsyt_2022_967779
crossref_primary_10_1007_s00213_025_06756_4
crossref_primary_10_1016_j_arr_2024_102198
crossref_primary_10_1007_s00787_020_01615_3
crossref_primary_10_1016_j_chmed_2024_07_004
crossref_primary_10_3389_fpsyt_2024_1356563
crossref_primary_10_1038_s41380_022_01564_0
crossref_primary_10_1038_s41398_019_0431_8
crossref_primary_10_1002_smi_3135
crossref_primary_10_1017_neu_2021_11
crossref_primary_10_1038_s41598_025_91840_0
crossref_primary_10_3390_dj10080143
crossref_primary_10_1186_s12974_021_02100_7
crossref_primary_10_1016_j_bbih_2022_100516
crossref_primary_10_1038_s41398_024_02869_0
crossref_primary_10_1016_j_bbih_2023_100631
crossref_primary_10_1038_s41398_021_01247_4
crossref_primary_10_3389_fgene_2022_813510
crossref_primary_10_1111_ejn_15239
crossref_primary_10_1186_s40337_022_00696_6
crossref_primary_10_1186_s12974_021_02229_5
crossref_primary_10_1080_13854046_2024_2335115
crossref_primary_10_1080_20008066_2025_2538906
crossref_primary_10_3390_bs15040530
crossref_primary_10_3389_fnmol_2024_1455418
crossref_primary_10_1016_j_anai_2020_10_007
crossref_primary_10_1016_j_psyneuen_2025_107405
crossref_primary_10_3389_fped_2021_734899
crossref_primary_10_7759_cureus_56661
crossref_primary_10_1016_j_pnpbp_2024_111139
crossref_primary_10_1016_j_jad_2023_04_080
crossref_primary_10_3389_fnagi_2024_1422862
crossref_primary_10_3758_s13415_020_00782_9
crossref_primary_10_1111_ejn_15009
crossref_primary_10_1016_j_bbrc_2024_149628
crossref_primary_10_1007_s40618_020_01457_5
crossref_primary_10_3390_ph17070846
crossref_primary_10_3389_fgene_2024_1394630
crossref_primary_10_3389_fnins_2021_650785
crossref_primary_10_1016_j_jpsychires_2024_08_027
crossref_primary_10_1038_s41398_022_01811_6
crossref_primary_10_1111_cpr_13295
crossref_primary_10_2147_NDT_S500337
crossref_primary_10_1016_j_pnpbp_2025_111501
crossref_primary_10_1007_s12035_021_02322_z
crossref_primary_10_1016_j_neubiorev_2024_105569
crossref_primary_10_3389_fmed_2024_1419801
crossref_primary_10_1016_j_phymed_2023_155032
crossref_primary_10_1186_s13054_022_04159_x
crossref_primary_10_1113_EP091762
crossref_primary_10_1016_j_jpsychires_2022_08_028
crossref_primary_10_1093_milmed_usz260
crossref_primary_10_1073_pnas_2406005121
crossref_primary_10_1016_j_bpsgos_2023_03_005
crossref_primary_10_3390_ijerph20042937
crossref_primary_10_3389_fpsyt_2023_1195012
crossref_primary_10_1111_ejn_15370
crossref_primary_10_1186_s12887_022_03552_3
crossref_primary_10_1007_s11033_024_09276_0
crossref_primary_10_1080_17435889_2025_2552103
crossref_primary_10_31718_2077_1096_25_1_139
crossref_primary_10_3390_biomedicines8070198
crossref_primary_10_1016_j_ajp_2020_102405
crossref_primary_10_1016_j_jpsychires_2023_07_018
crossref_primary_10_1007_s11926_021_01019_5
crossref_primary_10_3389_fnmol_2022_816182
crossref_primary_10_1186_s12889_020_09300_5
crossref_primary_10_1016_j_intimp_2023_111463
crossref_primary_10_2147_NDT_S535798
crossref_primary_10_1002_fsn3_2950
crossref_primary_10_3889_oamjms_2022_9059
crossref_primary_10_1016_j_jpsychores_2020_109976
crossref_primary_10_1016_j_gene_2023_147199
crossref_primary_10_1177_2470547020981670
crossref_primary_10_5493_wjem_v14_i4_96422
crossref_primary_10_1080_20008198_2021_1987655
crossref_primary_10_1038_s41380_025_03260_1
crossref_primary_10_1016_j_jad_2024_06_047
crossref_primary_10_1016_j_comppsych_2023_152388
crossref_primary_10_1038_s41398_022_01971_5
crossref_primary_10_1016_j_phymed_2022_154483
crossref_primary_10_1007_s11096_025_01931_1
crossref_primary_10_1016_j_neulet_2023_137056
crossref_primary_10_1080_20008066_2025_2494480
crossref_primary_10_15407_fz71_02_051
crossref_primary_10_3390_cells12182290
crossref_primary_10_3389_fpsyt_2024_1436690
crossref_primary_10_1093_rheumatology_keaf220
crossref_primary_10_1016_j_biopsych_2020_11_007
crossref_primary_10_3389_fgene_2021_649055
crossref_primary_10_1002_brb3_70073
crossref_primary_10_1159_000541592
crossref_primary_10_3390_ijms221910678
crossref_primary_10_3389_fnut_2024_1406366
crossref_primary_10_1016_j_immuni_2019_12_003
crossref_primary_10_4103_NRR_NRR_D_24_00054
crossref_primary_10_1097_PSY_0000000000001028
crossref_primary_10_1016_j_bbih_2021_100287
crossref_primary_10_1016_j_psychres_2019_05_044
crossref_primary_10_1007_s12144_024_07178_9
crossref_primary_10_1089_jchc_24_01_0008
crossref_primary_10_1016_j_bbi_2022_01_020
crossref_primary_10_5937_mp76_49506
crossref_primary_10_1038_s41380_024_02453_4
crossref_primary_10_1016_j_bbii_2023_100031
crossref_primary_10_3390_ijms24032080
crossref_primary_10_3389_fcell_2022_1059073
crossref_primary_10_1016_j_bbi_2023_08_029
crossref_primary_10_3389_fendo_2023_1149417
crossref_primary_10_1016_j_bbih_2023_100650
crossref_primary_10_3389_fpsyg_2024_1394014
crossref_primary_10_1016_j_neuropharm_2023_109728
crossref_primary_10_1016_j_bbi_2024_05_016
crossref_primary_10_1038_s41380_020_00920_2
crossref_primary_10_1093_psyrad_kkaf004
crossref_primary_10_1186_s12877_024_05209_5
crossref_primary_10_3389_fimmu_2025_1600206
crossref_primary_10_1186_s13041_023_00997_0
crossref_primary_10_1007_s12144_022_03510_3
crossref_primary_10_1016_j_ejphar_2025_178060
crossref_primary_10_1038_s41380_022_01776_4
crossref_primary_10_1016_j_phymed_2022_154139
crossref_primary_10_1016_j_psyneuen_2019_104491
crossref_primary_10_1177_15347354241285435
crossref_primary_10_1016_j_neulet_2020_135567
crossref_primary_10_1016_j_biochi_2024_05_006
crossref_primary_10_22141_2224_0713_21_1_2025_1144
crossref_primary_10_3389_fnins_2025_1540180
crossref_primary_10_1007_s00737_025_01570_5
crossref_primary_10_3389_fcvm_2022_852710
crossref_primary_10_1016_j_bbi_2022_12_012
crossref_primary_10_1016_j_jad_2020_10_045
crossref_primary_10_3390_biomedicines8120584
crossref_primary_10_31083_j_jin2304068
crossref_primary_10_3389_fpsyt_2020_533662
crossref_primary_10_1016_j_jpsychires_2024_08_041
crossref_primary_10_1242_dmm_050044
Cites_doi 10.1016/S0893-133X(00)00159-7
10.1016/j.brainresrev.2011.01.002
10.1159/000049028
10.1016/j.jpsychires.2006.06.009
10.1016/j.neuropharm.2014.10.023
10.1038/nn.4476
10.1016/j.psyneuen.2017.01.024
10.1016/j.biopsych.2012.06.029
10.1038/mp.2016.167
10.1016/j.psyneuen.2014.11.002
10.1038/npp.2017.220
10.1016/j.psychres.2017.11.061
10.1016/j.bbi.2008.09.010
10.1016/j.comppsych.2017.01.015
10.1038/tp.2014.56
10.1001/jamapsychiatry.2014.1611
10.1016/j.biopsych.2004.03.009
10.1001/archpsyc.1995.03950240066012
10.1002/gps.4236
10.1016/j.cellsig.2006.06.007
10.1038/mp.2015.9
10.1016/j.euroneuro.2011.06.001
10.7205/MILMED-D-17-00073
10.1016/j.bbi.2017.12.006
10.1196/annals.1364.005
10.1136/bmjopen-2016-011534
10.1152/ajpendo.00589.2007
10.1016/S0005-7967(00)00087-5
10.1016/j.bbi.2015.10.017
10.1016/j.psyneuen.2014.08.004
10.1002/da.20564
10.1176/appi.ajp.161.8.1488
10.1016/j.ahj.2013.07.031
10.1016/j.biopsych.2018.02.007
10.1038/mp.2015.67
10.1016/j.bbi.2010.12.001
10.1097/PSY.0000000000000512
10.1017/S0033291710002072
10.1001/archgenpsychiatry.2011.1539
10.1192/bjp.bp.116.197640
10.1016/j.pnpbp.2017.03.016
10.1016/S0079-6123(07)67012-5
10.1007/s00702-011-0741-3
10.1016/j.psychres.2017.01.072
10.1016/j.bbi.2017.11.013
10.1016/j.atherosclerosis.2014.06.011
10.1176/appi.ajp.157.8.1252
10.1016/j.bbi.2016.09.012
10.1016/j.yhbeh.2012.01.008
10.1176/ajp.156.4.585
10.1016/j.neulet.2016.06.023
10.1016/j.bbi.2016.10.014
10.1002/da.22511
10.1176/appi.ajp.2014.14020263
10.1016/j.expneurol.2016.05.014
10.1016/j.biopsych.2017.08.005
10.1016/j.biopsych.2015.05.017
10.1016/j.bbi.2017.10.025
10.1016/j.jpsychires.2012.12.001
10.1016/j.yfrne.2011.12.002
10.1016/j.biopsych.2009.09.033
10.1093/epirev/mxu011
10.1016/S0005-7967(99)00123-0
10.1016/j.bbi.2017.08.022
10.1176/appi.ajp.2010.09091379
10.1016/j.psyneuen.2014.10.022
10.1016/S0006-3223(98)00276-5
10.1037/hea0000593
10.1159/000336811
10.1016/j.biopsych.2013.01.007
10.4088/JCP.09m05106blu
10.1016/j.bbi.2009.04.005
10.1001/jama.2018.7028
10.1073/pnas.0910794107
10.1176/appi.ajp.158.3.484
10.1016/j.biopsych.2010.04.028
10.1034/j.1600-0447.2000.101001046.x
10.1038/npp.2016.125
10.1038/npp.2011.239
10.1016/j.cell.2017.12.025
10.1016/j.biopsych.2011.04.013
10.1016/j.jpsychores.2012.10.013
10.1111/acps.12217
10.1016/j.biopsych.2014.06.015
10.1016/j.tics.2011.04.004
10.1097/HRP.0b013e3182a75b7d
10.1016/j.diabet.2017.10.004
10.1073/pnas.0438019100
10.1038/s41583-018-0057-5
10.1016/j.expneurol.2016.05.038
10.1038/nri.2015.5
10.1186/1471-244X-13-40
10.1016/j.neuroscience.2015.05.018
10.1017/S0033291717000708
10.1016/j.psychres.2015.10.017
10.1016/j.jad.2018.02.061
10.1016/j.bbi.2015.06.012
10.1001/archgenpsychiatry.2011.50
10.1089/jwh.2010.2675
10.1016/S0006-3223(98)00246-7
10.1016/S0303-7207(01)00722-5
10.1016/j.jpsychires.2018.04.009
10.1097/JCP.0000000000000180
10.4088/JCP.11m07316
10.1016/j.cccn.2003.12.019
10.1016/j.schres.2017.04.015
10.1001/jamapsychiatry.2016.0350
10.4196/kjpp.2016.20.4.357
10.1001/archinte.1987.00370090055011
10.1016/j.biopsych.2003.11.018
10.1097/PSY.0b013e3181907c1b
10.1001/jamapsychiatry.2013.4374
10.1016/j.nlm.2014.10.001
10.1016/j.cpr.2012.02.002
10.1001/jama.299.11.1291
10.1152/ajpendo.90263.2008
10.1037/a0038039
10.1371/journal.pone.0111952
10.1016/j.tics.2006.04.007
10.1001/archgenpsychiatry.2010.71
10.1192/bjp.bp.114.148551
10.1111/j.1755-5949.2008.00071.x
10.1016/j.cyto.2011.03.025
10.3389/fphar.2018.00154
10.1016/j.bbi.2016.08.011
10.1002/ajmg.b.31212
10.1038/nrn2297
10.1016/j.psyneuen.2018.05.012
10.1017/S0007114511005460
10.1038/nrn.2016.155
10.1176/appi.books.9780890425596
10.1016/j.bbi.2013.01.081
10.1016/j.expneurol.2016.07.024
10.1038/npp.2017.162
10.1016/S2215-0366(15)00309-0
10.1007/s11011-014-9551-2
10.1002/da.22596
10.1186/1742-2094-9-275
10.1038/mp.2011.165
10.1002/jts.21848
10.1001/archgenpsychiatry.2010.61
10.1176/ajp.154.5.624
10.1210/er.2002-0006
10.1016/j.neuropharm.2012.10.002
10.1097/JES.0b013e3181b7b3d9
10.1523/JNEUROSCI.3112-10.2010
10.4088/JCP.16m11364
10.1016/j.concog.2011.02.003
10.1111/j.1600-0404.2004.00286.x
10.1038/nri3086
10.1037/0033-2909.133.2.183
10.1002/jts.20372
10.1038/nn.4030
10.1038/nature21363
10.1016/j.neubiorev.2014.04.003
10.1016/j.neuroimage.2011.10.090
10.1176/appi.ajp.159.10.1675
10.1016/j.jalz.2017.04.014
10.1016/S1995-7645(12)60048-0
ContentType Journal Article
Copyright 2019 The Authors. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
2019 The Authors. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology.
Copyright_xml – notice: 2019 The Authors. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
– notice: 2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
– notice: 2019 The Authors. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology.
DBID AAYXX
CITATION
7TK
K9.
7X8
DOI 10.1111/pcn.12820
DatabaseName CrossRef
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1819
EndPage 153
ExternalDocumentID 10_1111_pcn_12820
PCN12820
Genre reviewArticle
GrantInformation_xml – fundername: JSPS KAKENHI
  funderid: 16KT0198
– fundername: Japan Research Foundation for Clinical Pharmacology
– fundername: Takeda Science Foundation
– fundername: Health Labour Sciences Research Grant from the Japanese Ministry of Health, Labour and Welfare
  funderid: 201616028A
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TKC
TR2
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZXP
ZZTAW
~02
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
O8X
7TK
K9.
7X8
ID FETCH-LOGICAL-c4530-27eb41dfa2c8c83d95b6e76d39e28d2f470042318e35ebf0f045c3225de74d63
IEDL.DBID DRFUL
ISICitedReferencesCount 251
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000464279200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1323-1316
1440-1819
IngestDate Fri Sep 05 14:15:05 EDT 2025
Sat Nov 29 14:49:31 EST 2025
Tue Nov 18 22:20:09 EST 2025
Sat Nov 29 05:59:57 EST 2025
Wed Jan 22 17:10:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4530-27eb41dfa2c8c83d95b6e76d39e28d2f470042318e35ebf0f045c3225de74d63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4548-7110
PQID 2205148303
PQPubID 1106347
PageCount 11
ParticipantIDs proquest_miscellaneous_2179412086
proquest_journals_2205148303
crossref_citationtrail_10_1111_pcn_12820
crossref_primary_10_1111_pcn_12820
wiley_primary_10_1111_pcn_12820_PCN12820
PublicationCentury 2000
PublicationDate April 2019
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: April 2019
PublicationDecade 2010
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Tokyo
PublicationTitle Psychiatry and clinical neurosciences
PublicationYear 2019
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2015; 141
2017; 82
2010; 107
2015; 300
2013; 67
1997; 154
2015; 77
2004; 161
1999; 45
2011; 55
2002; 159
2012; 17
2014; 29
2018; 44
2018; 43
2016; 33
2014; 129
2010; 22
2018; 9
2017; 74
2018; 172
2011; 70
2017; 79
2011; 72
2017; 78
2008; 21
2011; 68
2011; 67
2010; 30
2018; 37
2009; 15
1995; 52
2007; 19
2017; 60
2015; 51
2018; 102
2015; 52
2010; 167
2017; 250
2012; 37
2018; 23
2016; 16
2012; 33
2012; 32
2016; 284
2014; 43
2004; 55
2018; 19
2016; 6
2018; 192
2017; 59
2009; 71
2013; 73
2018; 236
2004; 56
2013; 74
2015; 230
2016; 21
2003; 24
2016; 20
2001; 39
2018; 94
2000; 101
2017; 542
2003; 100
2014; 34
2001; 158
2012; 119
2012; 61
2017; 42
2015; 37
2013; 26
2017; 47
2013; 21
1987; 147
2015; 30
2016; 628
2008; 9
2013; 166
2018; 80
2011; 11
2016; 73
2018; 83
2011; 15
2012; 59
1998; 44
2010; 67
2015; 172
2014; 4
2010; 68
2013; 13
2007; 133
2002; 189
2017; 34
2011; 20
2011; 21
2018; 72
2011; 25
2016; 80
2012; 69
2014; 9
2006; 1071
2018; 79
2015; 2
2009; 23
2004; 342
2012; 81
2017; 20
2014; 116
2013; 47
2018; 260
2015; 18
2000; 157
2006; 10
2000; 23
2011; 156B
2015; 96
2016; 52
2011; 32
2016; 51
2015; 206
2018; 67
2008; 167
2017; 211
2009; 26
2014; 236
2018; 69
2012; 73
2004; 110
2000; 38
2011; 106
2017; 14
2015; 20
2001; 9
2013; 30
2011; 41
2017; 182
2018; 319
2017; 18
2013
2007; 41
1999; 156
2008; 299
2012; 5
2014; 71
2008; 295
2008; 294
2009; 37
2012; 9
e_1_2_9_75_1
e_1_2_9_98_1
e_1_2_9_52_1
e_1_2_9_79_1
e_1_2_9_94_1
e_1_2_9_10_1
e_1_2_9_56_1
e_1_2_9_33_1
e_1_2_9_90_1
e_1_2_9_103_1
e_1_2_9_126_1
e_1_2_9_149_1
e_1_2_9_107_1
e_1_2_9_122_1
e_1_2_9_145_1
e_1_2_9_14_1
e_1_2_9_141_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_160_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_6_1
e_1_2_9_119_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_138_1
e_1_2_9_111_1
e_1_2_9_134_1
e_1_2_9_157_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_130_1
e_1_2_9_153_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_99_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_95_1
e_1_2_9_76_1
e_1_2_9_91_1
e_1_2_9_102_1
e_1_2_9_148_1
e_1_2_9_129_1
e_1_2_9_144_1
e_1_2_9_106_1
e_1_2_9_125_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_140_1
e_1_2_9_163_1
e_1_2_9_121_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_84_1
e_1_2_9_23_1
e_1_2_9_65_1
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_114_1
e_1_2_9_137_1
e_1_2_9_118_1
e_1_2_9_133_1
e_1_2_9_156_1
e_1_2_9_9_1
e_1_2_9_152_1
e_1_2_9_27_1
e_1_2_9_69_1
e_1_2_9_110_1
e_1_2_9_31_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_96_1
e_1_2_9_12_1
e_1_2_9_54_1
e_1_2_9_92_1
e_1_2_9_109_1
e_1_2_9_101_1
e_1_2_9_128_1
e_1_2_9_105_1
e_1_2_9_124_1
e_1_2_9_147_1
e_1_2_9_39_1
e_1_2_9_162_1
e_1_2_9_120_1
e_1_2_9_16_1
e_1_2_9_58_1
e_1_2_9_143_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_89_1
Levin SG (e_1_2_9_88_1) 2017; 82
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
e_1_2_9_81_1
e_1_2_9_4_1
Baker DG (e_1_2_9_71_1) 1999; 156
e_1_2_9_113_1
e_1_2_9_159_1
Grassi‐Oliveira R (e_1_2_9_115_1) 2011; 32
e_1_2_9_117_1
e_1_2_9_155_1
e_1_2_9_136_1
e_1_2_9_151_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_132_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_97_1
e_1_2_9_93_1
e_1_2_9_108_1
e_1_2_9_70_1
e_1_2_9_127_1
e_1_2_9_100_1
e_1_2_9_104_1
e_1_2_9_146_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_142_1
e_1_2_9_161_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_86_1
e_1_2_9_7_1
e_1_2_9_82_1
e_1_2_9_3_1
e_1_2_9_112_1
e_1_2_9_139_1
e_1_2_9_116_1
e_1_2_9_135_1
e_1_2_9_158_1
e_1_2_9_25_1
e_1_2_9_131_1
e_1_2_9_154_1
e_1_2_9_48_1
Surís A (e_1_2_9_123_1) 2010; 22
e_1_2_9_29_1
e_1_2_9_150_1
References_xml – volume: 17
  start-page: 389
  year: 2012
  end-page: 401
  article-title: A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
  publication-title: Mol. Psychiatry
– volume: 236
  start-page: 108
  year: 2014
  end-page: 115
  article-title: Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
  publication-title: Atherosclerosis
– volume: 51
  start-page: 585
  year: 2015
  end-page: 588
  article-title: The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD‐associated nightmares: A preliminary randomized, double‐blind, placebo‐controlled cross‐over design study
  publication-title: Psychoneuroendocrinology
– volume: 55
  start-page: 74
  year: 2011
  end-page: 78
  article-title: C‐reactive protein, interleukin‐6, and posttraumatic stress disorder symptomology in urban police officers
  publication-title: Cytokine
– volume: 13
  start-page: 40
  year: 2013
  article-title: Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro‐inflammatory cytokines by peripheral blood mononuclear cells
  publication-title: BMC Psychiatry
– volume: 39
  start-page: 373
  year: 2001
  end-page: 393
  article-title: A cognitive neuroscience account of posttraumatic stress disorder and its treatment
  publication-title: Behav. Res. Ther.
– volume: 129
  start-page: 180
  year: 2014
  end-page: 192
  article-title: Childhood maltreatment and inflammatory markers: A systematic review
  publication-title: Acta Psychiatr. Scand.
– volume: 11
  start-page: 775
  year: 2011
  end-page: 787
  article-title: Microglial cell origin and phenotypes in health and disease
  publication-title: Nat. Rev. Immunol.
– volume: 52
  start-page: 169
  year: 2016
  end-page: 177
  article-title: Candesartan ameliorates impaired fear extinction induced by innate immune activation
  publication-title: Brain Behav. Immun.
– volume: 102
  start-page: 192
  year: 2018
  end-page: 200
  article-title: Inflammatory markers and their possible effects on cognitive function in women with posttraumatic stress disorder
  publication-title: J. Psychiatr. Res.
– volume: 211
  start-page: 280
  year: 2017
  end-page: 288
  article-title: Childhood adversities and post‐traumatic stress disorder: Evidence for stress sensitisation in the World Mental Health Surveys
  publication-title: Br. J. Psychiatry
– volume: 71
  start-page: 1381
  year: 2014
  end-page: 1391
  article-title: Effect of anti‐inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta‐analysis of randomized clinical trials
  publication-title: JAMA Psychiatry
– volume: 44
  start-page: 1305
  year: 1998
  end-page: 1313
  article-title: Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event
  publication-title: Biol. Psychiatry
– volume: 18
  start-page: 965
  year: 2015
  end-page: 977
  article-title: Host microbiota constantly control maturation and function of microglia in the CNS
  publication-title: Nat. Neurosci.
– volume: 43
  start-page: 163
  year: 2014
  end-page: 172
  article-title: Grey matter reduction associated with posttraumatic stress disorder and traumatic stress
  publication-title: Neurosci. Biobehav. Rev.
– volume: 51
  start-page: 1
  year: 2016
  end-page: 11
  article-title: Mind‐body therapies and control of inflammatory biology: A descriptive review
  publication-title: Brain Behav. Immun.
– volume: 250
  start-page: 136
  year: 2017
  end-page: 140
  article-title: Resilience to traumatic events related to urban violence and increased IL10 serum levels
  publication-title: Psychiatry Res.
– volume: 51
  start-page: 589
  year: 2015
  end-page: 597
  article-title: Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome
  publication-title: Psychoneuroendocrinology
– volume: 19
  start-page: 251
  year: 2007
  end-page: 260
  article-title: Beta2 adrenergic receptor activation stimulates pro‐inflammatory cytokine production in macrophages via PKA‐ and NF‐kappaB‐independent mechanisms
  publication-title: Cell. Signal.
– volume: 73
  start-page: 849
  year: 2012
  end-page: 855
  article-title: The renin‐angiotensin pathway in posttraumatic stress disorder: Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms
  publication-title: J. Clin. Psychiatry
– volume: 94
  start-page: 143
  year: 2018
  end-page: 151
  article-title: A peripheral immune response to remembering trauma contributes to the maintenance of fear memory in mice
  publication-title: Psychoneuroendocrinology
– volume: 61
  start-page: 380
  year: 2012
  end-page: 391
  article-title: Oxytocin and social affiliation in humans
  publication-title: Horm. Behav.
– volume: 37
  start-page: 567
  year: 2012
  end-page: 580
  article-title: Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus
  publication-title: Neuropsychopharmacology
– volume: 154
  start-page: 624
  year: 1997
  end-page: 629
  article-title: Elevated CSF corticotropin‐releasing factor concentrations in posttraumatic stress disorder
  publication-title: Am. J. Psychiatry
– volume: 32
  start-page: 301
  year: 2012
  end-page: 315
  article-title: Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta‐analysis
  publication-title: Clin. Psychol. Rev.
– volume: 41
  start-page: 744
  year: 2007
  end-page: 752
  article-title: Evidence for low‐grade systemic proinflammatory activity in patients with posttraumatic stress disorder
  publication-title: J. Psychiatr. Res.
– volume: 69
  start-page: 360
  year: 2012
  end-page: 371
  article-title: Dorsolateral prefrontal cortex activation during emotional anticipation and neuropsychological performance in posttraumatic stress disorder
  publication-title: Arch. Gen. Psychiatry
– volume: 80
  start-page: 291
  year: 2018
  end-page: 294
  article-title: The anti‐inflammatory mechanism of antidepressants ‐ SSRIs, SNRIs
  publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry
– volume: 4
  start-page: e413
  year: 2014
  article-title: Association of trauma exposure with proinflammatory activity: A transdiagnostic meta‐analysis
  publication-title: Transl. Psychiatry
– volume: 119
  start-page: 245
  year: 2012
  end-page: 251
  article-title: The role of the kynurenine metabolism in major depression
  publication-title: J. Neural Transm.
– volume: 342
  start-page: 93
  year: 2004
  end-page: 98
  article-title: The inflammatory markers C‐reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder
  publication-title: Clin. Chim. Acta
– volume: 110
  start-page: 124
  year: 2004
  end-page: 127
  article-title: Elevated interleukin‐6 levels in cerebrospinal fluid of vascular dementia patients
  publication-title: Acta Neurol. Scand.
– volume: 260
  start-page: 111
  year: 2018
  end-page: 115
  article-title: Serum levels of interleukins IL‐6 and IL‐10 in individuals with posttraumatic stress disorder in a population‐based sample
  publication-title: Psychiatry Res.
– volume: 299
  start-page: 1291
  year: 2008
  end-page: 1305
  article-title: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults
  publication-title: JAMA
– volume: 67
  start-page: 157
  year: 2011
  end-page: 183
  article-title: Interleukin‐6, a mental cytokine
  publication-title: Brain Res. Rev.
– volume: 74
  start-page: 15
  year: 2013
  end-page: 25
  article-title: Cytokine alterations in bipolar disorder: A meta‐analysis of 30 studies
  publication-title: Biol. Psychiatry
– volume: 23
  start-page: 887
  year: 2009
  end-page: 897
  article-title: To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers
  publication-title: Brain Behav. Immun.
– volume: 2
  start-page: 1002
  year: 2015
  end-page: 1012
  article-title: Inflammatory markers in post‐traumatic stress disorder: A systematic review, meta‐analysis, and meta‐regression
  publication-title: Lancet Psychiatry
– volume: 18
  start-page: 7
  year: 2017
  end-page: 19
  article-title: Stress, glucocorticoids and memory: Implications for treating fear‐related disorders
  publication-title: Nat. Rev. Neurosci.
– volume: 20
  start-page: 1141
  year: 2011
  end-page: 1149
  article-title: The association of posttraumatic stress disorder with fast food and soda consumption and unhealthy weight loss behaviors among young women
  publication-title: J. Womens Health (Larchmt.)
– volume: 9
  start-page: 275
  year: 2012
  article-title: L‐glutamate released from activated microglia downregulates astrocytic L‐glutamate transporter expression in neuroinflammation: The 'collusion' hypothesis for increased extracellular L‐glutamate concentration in neuroinflammation
  publication-title: J. Neuroinflammation
– volume: 67
  start-page: 608
  year: 2010
  end-page: 613
  article-title: Posttraumatic stress disorder and risk of dementia among US veterans
  publication-title: Arch. Gen. Psychiatry
– volume: 294
  start-page: E506
  year: 2008
  end-page: E512
  article-title: Stimulation of both type I and type II corticosteroid receptors blunts counterregulatory responses to subsequent hypoglycemia in healthy man
  publication-title: Am. J. Physiol. Endocrinol. Metab.
– volume: 71
  start-page: 171
  year: 2009
  end-page: 186
  article-title: Associations of depression with C‐reactive protein, IL‐1, and IL‐6: A meta‐analysis
  publication-title: Psychosom. Med.
– volume: 147
  start-page: 1577
  year: 1987
  end-page: 1580
  article-title: Psychiatric complications of long‐term interferon alfa therapy
  publication-title: Arch. Intern. Med.
– volume: 182
  start-page: e1815
  year: 2017
  end-page: e1818
  article-title: The role of inflammation in late‐life post‐traumatic stress disorder
  publication-title: Mil. Med.
– volume: 158
  start-page: 484
  year: 2001
  end-page: 486
  article-title: Suppression of cellular immunity in men with a past history of posttraumatic stress disorder
  publication-title: Am. J. Psychiatry
– volume: 52
  start-page: 92
  year: 2015
  end-page: 110
  article-title: The brain mineralocorticoid receptor and stress resilience
  publication-title: Psychoneuroendocrinology
– volume: 107
  start-page: 9470
  year: 2010
  end-page: 9475
  article-title: Epigenetic and immune function profiles associated with posttraumatic stress disorder
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 80
  start-page: 23
  year: 2016
  end-page: 32
  article-title: Early‐life adversity and physical and emotional health across the lifespan: A neuroimmune network hypothesis
  publication-title: Biol. Psychiatry
– volume: 284
  start-page: 181
  year: 2016
  end-page: 195
  article-title: Noradrenergic dysregulation in the pathophysiology of PTSD
  publication-title: Exp. Neurol.
– volume: 21
  start-page: 642
  year: 2016
  end-page: 649
  article-title: Childhood trauma and adulthood inflammation: A meta‐analysis of peripheral C‐reactive protein, interleukin‐6 and tumour necrosis factor‐alpha
  publication-title: Mol. Psychiatry
– volume: 34
  start-page: 207
  year: 2017
  end-page: 216
  article-title: Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review
  publication-title: Depress. Anxiety
– volume: 73
  start-page: 70
  year: 2013
  end-page: 74
  article-title: Gray matter correlates of posttraumatic stress disorder: A quantitative meta‐analysis
  publication-title: Biol. Psychiatry
– volume: 15
  start-page: 280
  year: 2011
  end-page: 288
  article-title: Stress and emotional memory: A matter of timing
  publication-title: Trends Cogn. Sci.
– volume: 14
  start-page: 28
  year: 2017
  end-page: 34
  article-title: Post‐traumatic stress disorder and risk of dementia among members of a health care delivery system
  publication-title: Alzheimers Dement.
– volume: 30
  start-page: 156
  year: 2015
  end-page: 165
  article-title: C‐reactive protein plays a marginal role in cognitive decline: A systematic review and meta‐analysis
  publication-title: Int. J. Geriatr. Psychiatry
– volume: 15
  start-page: 84
  year: 2009
  end-page: 88
  article-title: The use of a synthetic cannabinoid in the management of treatment‐resistant nightmares in posttraumatic stress disorder (PTSD)
  publication-title: CNS Neurosci. Ther.
– volume: 59
  start-page: 313
  year: 2017
  end-page: 321
  article-title: Microglial production of TNF‐alpha is a key element of sustained fear memory
  publication-title: Brain Behav. Immun.
– volume: 96
  start-page: 42
  year: 2015
  end-page: 54
  article-title: IL‐6 regulation of synaptic function in the CNS
  publication-title: Neuropharmacology
– volume: 78
  start-page: 93
  year: 2017
  end-page: 96
  article-title: Threat‐related amygdala activity is associated with peripheral CRP concentrations in men but not women
  publication-title: Psychoneuroendocrinology
– volume: 16
  start-page: 22
  year: 2016
  end-page: 34
  article-title: The role of inflammation in depression: From evolutionary imperative to modern treatment target
  publication-title: Nat. Rev. Immunol.
– volume: 542
  start-page: 177
  year: 2017
  end-page: 185
  article-title: Inflammation, metaflammation and immunometabolic disorders
  publication-title: Nature
– volume: 21
  start-page: 530
  year: 2008
  end-page: 539
  article-title: Low cortisol, high DHEA, and high levels of stimulated TNF‐alpha, and IL‐6 in women with PTSD
  publication-title: J. Trauma. Stress
– volume: 206
  start-page: 93
  year: 2015
  end-page: 100
  article-title: Pharmacotherapy for post‐traumatic stress disorder: Systematic review and meta‐analysis
  publication-title: Br. J. Psychiatry
– volume: 71
  start-page: 423
  year: 2014
  end-page: 431
  article-title: Assessment of plasma C‐reactive protein as a biomarker of posttraumatic stress disorder risk
  publication-title: JAMA Psychiatry
– volume: 30
  start-page: 12725
  year: 2010
  end-page: 12732
  article-title: Time‐dependent effects of corticosteroids on human amygdala processing
  publication-title: J. Neurosci.
– volume: 161
  start-page: 1488
  year: 2004
  end-page: 1490
  article-title: Low‐dose cortisol for symptoms of posttraumatic stress disorder
  publication-title: Am. J. Psychiatry
– volume: 189
  start-page: 1
  year: 2002
  end-page: 9
  article-title: The anti‐inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis
  publication-title: Mol. Cell. Endocrinol.
– volume: 77
  start-page: 365
  year: 2015
  end-page: 374
  article-title: Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder
  publication-title: Biol. Psychiatry
– volume: 42
  start-page: 36
  year: 2017
  end-page: 45
  article-title: Danger signals and inflammasomes: Stress‐evoked sterile inflammation in mood disorders
  publication-title: Neuropsychopharmacology
– volume: 68
  start-page: 433
  year: 2010
  end-page: 441
  article-title: Exaggerated and disconnected insular‐amygdalar blood oxygenation level‐dependent response to threat‐related emotional faces in women with intimate‐partner violence posttraumatic stress disorder
  publication-title: Biol. Psychiatry
– volume: 59
  start-page: 3222
  year: 2012
  end-page: 3226
  article-title: Inflammation selectively enhances amygdala activity to socially threatening images
  publication-title: Neuroimage
– volume: 79
  year: 2018
  article-title: Toward understanding sex differences in the prevalence of posttraumatic stress disorder: Results from the National Epidemiologic Survey on alcohol and related conditions
  publication-title: J. Clin. Psychiatry
– volume: 5
  start-page: 323
  year: 2012
  end-page: 325
  article-title: Study on serum cytokine levels in posttraumatic stress disorder patients
  publication-title: Asian Pac. J. Trop. Med.
– volume: 69
  start-page: 321
  year: 2018
  end-page: 335
  article-title: Glia‐ and tissue‐specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone
  publication-title: Brain Behav. Immun.
– volume: 32
  start-page: 540
  year: 2011
  end-page: 544
  article-title: Interleukin‐6 and verbal memory in recurrent major depressive disorder
  publication-title: Neuro Endocrinol. Lett.
– volume: 1071
  start-page: 46
  year: 2006
  end-page: 53
  article-title: Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 22
  start-page: 274
  year: 2010
  end-page: 279
  article-title: Effects of exogenous glucocorticoid on combat‐related PTSD symptoms
  publication-title: Ann. Clin. Psychiatry
– volume: 295
  start-page: E686
  year: 2008
  end-page: E691
  article-title: Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men
  publication-title: Am. J. Physiol. Endocrinol. Metab.
– year: 2013
– volume: 172
  start-page: 22
  year: 2018
  end-page: 40
  article-title: An integrated view of immunometabolism
  publication-title: Cell
– volume: 192
  start-page: 16
  year: 2018
  end-page: 29
  article-title: Cytokines and C‐reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review
  publication-title: Schizophr. Res.
– volume: 9
  year: 2014
  article-title: ACE inhibitors potently reduce vascular inflammation, results of an open proof‐of‐concept study in the abdominal aortic aneurysm
  publication-title: PLoS One.
– volume: 21
  start-page: 219
  year: 2013
  end-page: 247
  article-title: The role of oxytocin in psychiatric disorders: A review of biological and therapeutic research findings
  publication-title: Harv. Rev. Psychiatry
– volume: 83
  start-page: 61
  year: 2018
  end-page: 69
  article-title: Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: A positron emission tomography study
  publication-title: Biol. Psychiatry
– volume: 47
  start-page: 401
  year: 2013
  end-page: 406
  article-title: Increased cerebrospinal fluid interleukin‐6 levels in patients with schizophrenia and those with major depressive disorder
  publication-title: J. Psychiatr. Res.
– volume: 67
  start-page: 712
  year: 2010
  end-page: 719
  article-title: Prospectively ascertained child maltreatment and its association with DSM‐IV mental disorders in young adults
  publication-title: Arch. Gen. Psychiatry
– volume: 628
  start-page: 85
  year: 2016
  end-page: 90
  article-title: Plasma interleukin‐6 and executive function in crack cocaine‐dependent women
  publication-title: Neurosci. Lett.
– volume: 21
  start-page: 796
  year: 2011
  end-page: 809
  article-title: High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies
  publication-title: Eur. Neuropsychopharmacol.
– volume: 43
  start-page: 469
  year: 2018
  end-page: 481
  article-title: PTSD blood transcriptome mega‐analysis: Shared inflammatory pathways across biological sex and modes of trauma
  publication-title: Neuropsychopharmacology
– volume: 68
  start-page: 901
  year: 2011
  end-page: 910
  article-title: Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: Evidence from endocrine and gene expression studies
  publication-title: Arch. Gen. Psychiatry
– volume: 236
  start-page: 306
  year: 2018
  end-page: 312
  article-title: Cognitive function in Japanese women with posttraumatic stress disorder: Association with exercise habits
  publication-title: J. Affect. Disord.
– volume: 52
  start-page: 1048
  year: 1995
  end-page: 1060
  article-title: Posttraumatic stress disorder in the National Comorbidity Survey
  publication-title: Arch. Gen. Psychiatry
– volume: 167
  start-page: 171
  year: 2008
  end-page: 186
  article-title: Structural and functional plasticity of the human brain in posttraumatic stress disorder
  publication-title: Prog. Brain Res.
– volume: 74
  start-page: 301
  year: 2013
  end-page: 306
  article-title: Women in recovery from PTSD have similar inflammation and quality of life as non‐traumatized controls
  publication-title: J. Psychosom. Res.
– volume: 19
  start-page: 622
  year: 2018
  end-page: 635
  article-title: Microglial signatures and their role in health and disease
  publication-title: Nat. Rev. Neurosci.
– volume: 83
  start-page: 866
  year: 2018
  end-page: 875
  article-title: Metabolism, metabolomics, and inflammation in posttraumatic stress disorder
  publication-title: Biol. Psychiatry
– volume: 59
  start-page: 260
  year: 2017
  end-page: 264
  article-title: Increased pro‐inflammatory milieu in combat related PTSD: A new cohort replication study
  publication-title: Brain Behav. Immun.
– volume: 9
  start-page: 46
  year: 2008
  end-page: 56
  article-title: From inflammation to sickness and depression: When the immune system subjugates the brain
  publication-title: Nat. Rev. Neurosci.
– volume: 43
  start-page: 80
  year: 2018
  end-page: 102
  article-title: Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder
  publication-title: Neuropsychopharmacology
– volume: 284
  start-page: 220
  year: 2016
  end-page: 229
  article-title: Posttraumatic stress disorder: A metabolic disorder in disguise?
  publication-title: Exp. Neurol.
– volume: 55
  start-page: 745
  year: 2004
  end-page: 751
  article-title: Hypocortisolism and increased glucocorticoid sensitivity of pro‐inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder
  publication-title: Biol. Psychiatry
– volume: 44
  start-page: 292
  year: 2018
  end-page: 295
  article-title: Inhibitory role of oxytocin on TNFα expression assessed in vitro and in vivo
  publication-title: Diabetes Metab.
– volume: 37
  start-page: 407
  year: 2018
  end-page: 416
  article-title: Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co‐occuring smoking: A systematic review and meta‐analysis
  publication-title: Health Psychol.
– volume: 45
  start-page: 817
  year: 1999
  end-page: 826
  article-title: Brain activation in PTSD in response to trauma‐related stimuli
  publication-title: Biol. Psychiatry
– volume: 25
  start-page: 524
  year: 2011
  end-page: 531
  article-title: Suppressed monocyte gene expression profile in men versus women with PTSD
  publication-title: Brain Behav. Immun.
– volume: 9
  start-page: 154
  year: 2018
  article-title: The associations between oxytocin and trauma in humans: A systematic review
  publication-title: Front. Pharmacol.
– volume: 167
  start-page: 748
  year: 2010
  end-page: 751
  article-title: Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders
  publication-title: Am. J. Psychiatry
– volume: 34
  start-page: 559
  year: 2014
  end-page: 564
  article-title: Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder‐related insomnia and nightmares, chronic pain, harm reduction, and other indications: A retrospective evaluation
  publication-title: J. Clin. Psychopharmacol.
– volume: 37
  start-page: 103
  year: 2015
  end-page: 115
  article-title: Post‐traumatic stress disorder, physical activity, and eating behaviors
  publication-title: Epidemiol. Rev.
– volume: 23
  start-page: 335
  year: 2018
  end-page: 343
  article-title: Antidepressant activity of anti‐cytokine treatment: A systematic review and meta‐analysis of clinical trials of chronic inflammatory conditions
  publication-title: Mol. Psychiatry
– volume: 26
  start-page: 537
  year: 2013
  end-page: 547
  article-title: National estimates of exposure to traumatic events and PTSD prevalence using DSM‐IV and DSM‐5 criteria
  publication-title: J. Trauma. Stress
– volume: 41
  start-page: 1497
  year: 2011
  end-page: 1505
  article-title: Common genetic and environmental contributions to post‐traumatic stress disorder and alcohol dependence in young women
  publication-title: Psychol. Med.
– volume: 60
  start-page: 198
  year: 2017
  end-page: 205
  article-title: Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study
  publication-title: Brain Behav. Immun.
– volume: 38
  start-page: 319
  year: 2000
  end-page: 345
  article-title: A cognitive model of posttraumatic stress disorder
  publication-title: Behav. Res. Ther.
– volume: 166
  start-page: 806
  year: 2013
  end-page: 814
  article-title: Posttraumatic stress disorder and risk for coronary heart disease: A meta‐analytic review
  publication-title: Am. Heart J.
– volume: 20
  start-page: 357
  year: 2016
  end-page: 366
  article-title: Effects of systemic administration of ibuprofen on stress response in a rat model of post‐traumatic stress disorder
  publication-title: Korean J. Physiol. Pharmacol.
– volume: 23
  start-page: 225
  year: 2009
  end-page: 231
  article-title: Repeated social defeat activates dendritic cells and enhances toll‐like receptor dependent cytokine secretion
  publication-title: Brain Behav. Immun.
– volume: 156B
  start-page: 700
  year: 2011
  end-page: 708
  article-title: Differential immune system DNA methylation and cytokine regulation in post‐traumatic stress disorder
  publication-title: Am. J. Med. Genet. B Neuropsychiatr. Genet.
– volume: 20
  start-page: 1154
  year: 2011
  end-page: 1162
  article-title: Influences of menstrual cycle position and sex hormone levels on spontaneous intrusive recollections following emotional stimuli
  publication-title: Conscious. Cogn.
– volume: 159
  start-page: 1675
  year: 2002
  end-page: 1681
  article-title: Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: A twin study
  publication-title: Am. J. Psychiatry
– volume: 116
  start-page: 145
  year: 2014
  end-page: 154
  article-title: Low levels of estradiol are associated with elevated conditioned responding during fear extinction and with intrusive memories in daily life
  publication-title: Neurobiol. Learn. Mem.
– volume: 133
  start-page: 183
  year: 2007
  end-page: 204
  article-title: Gender differences in posttraumatic stress disorder
  publication-title: Psychol. Bull.
– volume: 82
  start-page: 264
  year: 2017
  end-page: 274
  article-title: Modulating effect of cytokines on mechanisms of synaptic plasticity in the brain
  publication-title: Biochemistry
– volume: 106
  start-page: S5
  year: 2011
  end-page: S78
  article-title: Dietary factors and low‐grade inflammation in relation to overweight and obesity
  publication-title: Br. J. Nutr.
– volume: 79
  start-page: 936
  year: 2017
  end-page: 946
  article-title: The microbiome in posttraumatic stress disorder and trauma‐exposed controls: An exploratory study
  publication-title: Psychosom. Med.
– volume: 26
  start-page: 447
  year: 2009
  end-page: 455
  article-title: Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder
  publication-title: Depress. Anxiety
– volume: 69
  start-page: 203
  year: 2018
  end-page: 209
  article-title: Posttraumatic stress disorder onset and inflammatory and endothelial function biomarkers in women
  publication-title: Brain Behav. Immun.
– volume: 300
  start-page: 141
  year: 2015
  end-page: 154
  article-title: The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
  publication-title: Neuroscience
– volume: 33
  start-page: 792
  year: 2016
  end-page: 806
  article-title: Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta‐analyses to determine first‐line treatments
  publication-title: Depress. Anxiety
– volume: 24
  start-page: 488
  year: 2003
  end-page: 522
  article-title: The interplay between the glucocorticoid receptor and nuclear factor‐kappaB or activator protein‐1: Molecular mechanisms for gene repression
  publication-title: Endocr. Rev.
– volume: 72
  start-page: 2
  year: 2018
  end-page: 13
  article-title: Depression and sterile inflammation: Essential role of danger associated molecular patterns
  publication-title: Brain Behav. Immun.
– volume: 20
  start-page: 1538
  year: 2015
  end-page: 1545
  article-title: Gene networks specific for innate immunity define post‐traumatic stress disorder
  publication-title: Mol. Psychiatry
– volume: 100
  start-page: 1920
  year: 2003
  end-page: 1925
  article-title: A mechanism converting psychosocial stress into mononuclear cell activation
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 20
  start-page: 145
  year: 2017
  end-page: 155
  article-title: Interactions between the microbiota, immune and nervous systems in health and disease
  publication-title: Nat. Neurosci.
– volume: 101
  start-page: 46
  year: 2000
  end-page: 59
  article-title: Traumatic events and post‐traumatic stress disorder in the community: Prevalence, risk factors and comorbidity
  publication-title: Acta Psychiatr. Scand.
– volume: 72
  start-page: 1124
  year: 2011
  end-page: 1128
  article-title: Corticotropin‐releasing factor, interleukin‐6, brain‐derived neurotrophic factor, insulin‐like growth factor‐1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine
  publication-title: J. Clin. Psychiatry
– volume: 10
  start-page: 271
  year: 2006
  end-page: 277
  article-title: Cognitive abnormalities in post‐traumatic stress disorder
  publication-title: Trends Cogn. Sci.
– volume: 284
  start-page: 133
  year: 2016
  end-page: 140
  article-title: New translational perspectives for blood‐based biomarkers of PTSD: From glucocorticoid to immune mediators of stress susceptibility
  publication-title: Exp. Neurol.
– volume: 156
  start-page: 585
  year: 1999
  end-page: 588
  article-title: Serial CSF corticotropin‐releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
  publication-title: Am. J. Psychiatry
– volume: 67
  start-page: 304
  year: 2013
  end-page: 317
  article-title: A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti‐inflammatory properties and how relevant is this in the treatment of depression?
  publication-title: Neuropharmacology
– volume: 157
  start-page: 1252
  year: 2000
  end-page: 1259
  article-title: Low cortisol and risk for PTSD in adult offspring of holocaust survivors
  publication-title: Am. J. Psychiatry
– volume: 70
  start-page: 663
  year: 2011
  end-page: 671
  article-title: Meta‐analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects
  publication-title: Biol. Psychiatry
– volume: 33
  start-page: 116
  year: 2012
  end-page: 125
  article-title: Cytokines and brain excitability
  publication-title: Front. Neuroendocrinol.
– volume: 67
  start-page: 194
  year: 2018
  end-page: 202
  article-title: CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C‐reactive protein
  publication-title: Brain Behav. Immun.
– volume: 23
  start-page: 477
  year: 2000
  end-page: 501
  article-title: The corticosteroid receptor hypothesis of depression
  publication-title: Neuropsychopharmacology
– volume: 319
  start-page: 2388
  year: 2018
  end-page: 2400
  article-title: Association of stress‐related disorders with subsequent autoimmune disease
  publication-title: JAMA
– volume: 56
  start-page: 121
  year: 2004
  end-page: 128
  article-title: Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder
  publication-title: Biol. Psychiatry
– volume: 73
  start-page: 695
  year: 2016
  end-page: 704
  article-title: Genome‐wide association studies of posttraumatic stress disorder in 2 cohorts of US Army soldiers
  publication-title: JAMA Psychiatry
– volume: 30
  start-page: 125
  year: 2013
  end-page: 132
  article-title: Association between posttraumatic stress disorder and inflammation: A twin study
  publication-title: Brain Behav. Immun.
– volume: 172
  start-page: 353
  year: 2015
  end-page: 362
  article-title: Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma
  publication-title: Am. J. Psychiatry
– volume: 47
  start-page: 2260
  year: 2017
  end-page: 2274
  article-title: Posttraumatic stress disorder in the World Mental Health Surveys
  publication-title: Psychol. Med.
– volume: 6
  year: 2016
  article-title: Association between psychological distress and dietary intake among evacuees after the Great East Japan Earthquake in a cross‐sectional study: The Fukushima Health Management Survey
  publication-title: BMJ Open
– volume: 67
  start-page: 446
  year: 2010
  end-page: 457
  article-title: A meta‐analysis of cytokines in major depression
  publication-title: Biol. Psychiatry
– volume: 141
  start-page: 105
  year: 2015
  end-page: 140
  article-title: A quantitative meta‐analysis of neurocognitive functioning in posttraumatic stress disorder
  publication-title: Psychol. Bull.
– volume: 81
  start-page: 315
  year: 2012
  end-page: 317
  article-title: Fish oil for attenuating posttraumatic stress symptoms among rescue workers after the Great East Japan Earthquake: A randomized controlled trial
  publication-title: Psychother. Psychosom.
– volume: 29
  start-page: 593
  year: 2014
  end-page: 608
  article-title: Interleukin 6 and cognitive dysfunction
  publication-title: Metab. Brain Dis.
– volume: 230
  start-page: 130
  year: 2015
  end-page: 136
  article-title: Physical activity in the treatment of post‐traumatic stress disorder: A systematic review and meta‐analysis
  publication-title: Psychiatry Res.
– volume: 74
  start-page: 125
  year: 2017
  end-page: 133
  article-title: Genetic and serum biomarker evidence for a relationship between TNFα and PTSD in Vietnam War combat veterans
  publication-title: Compr. Psychiatry
– volume: 9
  start-page: 209
  year: 2001
  end-page: 217
  article-title: Plasma and cerebrospinal fluid interleukin‐6 concentrations in posttraumatic stress disorder
  publication-title: Neuroimmunomodulation
– volume: 37
  start-page: 165
  year: 2009
  end-page: 170
  article-title: Exercise training as a treatment for chronic inflammation in the elderly
  publication-title: Exerc. Sport Sci. Rev.
– ident: e_1_2_9_76_1
  doi: 10.1016/S0893-133X(00)00159-7
– ident: e_1_2_9_113_1
  doi: 10.1016/j.brainresrev.2011.01.002
– ident: e_1_2_9_41_1
  doi: 10.1159/000049028
– ident: e_1_2_9_50_1
  doi: 10.1016/j.jpsychires.2006.06.009
– ident: e_1_2_9_112_1
  doi: 10.1016/j.neuropharm.2014.10.023
– ident: e_1_2_9_152_1
  doi: 10.1038/nn.4476
– ident: e_1_2_9_101_1
  doi: 10.1016/j.psyneuen.2017.01.024
– ident: e_1_2_9_110_1
  doi: 10.1016/j.biopsych.2012.06.029
– ident: e_1_2_9_131_1
  doi: 10.1038/mp.2016.167
– ident: e_1_2_9_128_1
  doi: 10.1016/j.psyneuen.2014.11.002
– ident: e_1_2_9_22_1
  doi: 10.1038/npp.2017.220
– ident: e_1_2_9_27_1
  doi: 10.1016/j.psychres.2017.11.061
– ident: e_1_2_9_61_1
  doi: 10.1016/j.bbi.2008.09.010
– ident: e_1_2_9_28_1
  doi: 10.1016/j.comppsych.2017.01.015
– ident: e_1_2_9_38_1
  doi: 10.1038/tp.2014.56
– ident: e_1_2_9_129_1
  doi: 10.1001/jamapsychiatry.2014.1611
– ident: e_1_2_9_145_1
  doi: 10.1016/j.biopsych.2004.03.009
– ident: e_1_2_9_43_1
  doi: 10.1001/archpsyc.1995.03950240066012
– ident: e_1_2_9_119_1
  doi: 10.1002/gps.4236
– ident: e_1_2_9_68_1
  doi: 10.1016/j.cellsig.2006.06.007
– ident: e_1_2_9_52_1
  doi: 10.1038/mp.2015.9
– ident: e_1_2_9_133_1
  doi: 10.1016/j.euroneuro.2011.06.001
– ident: e_1_2_9_30_1
  doi: 10.7205/MILMED-D-17-00073
– ident: e_1_2_9_94_1
  doi: 10.1016/j.bbi.2017.12.006
– ident: e_1_2_9_132_1
  doi: 10.1196/annals.1364.005
– ident: e_1_2_9_148_1
  doi: 10.1136/bmjopen-2016-011534
– ident: e_1_2_9_74_1
  doi: 10.1152/ajpendo.00589.2007
– ident: e_1_2_9_4_1
  doi: 10.1016/S0005-7967(00)00087-5
– ident: e_1_2_9_97_1
  doi: 10.1016/j.bbi.2015.10.017
– ident: e_1_2_9_124_1
  doi: 10.1016/j.psyneuen.2014.08.004
– ident: e_1_2_9_33_1
  doi: 10.1002/da.20564
– ident: e_1_2_9_122_1
  doi: 10.1176/appi.ajp.161.8.1488
– ident: e_1_2_9_9_1
  doi: 10.1016/j.ahj.2013.07.031
– ident: e_1_2_9_8_1
  doi: 10.1016/j.biopsych.2018.02.007
– ident: e_1_2_9_48_1
  doi: 10.1038/mp.2015.67
– ident: e_1_2_9_23_1
  doi: 10.1016/j.bbi.2010.12.001
– ident: e_1_2_9_154_1
  doi: 10.1097/PSY.0000000000000512
– ident: e_1_2_9_159_1
  doi: 10.1017/S0033291710002072
– ident: e_1_2_9_108_1
  doi: 10.1001/archgenpsychiatry.2011.1539
– ident: e_1_2_9_45_1
  doi: 10.1192/bjp.bp.116.197640
– ident: e_1_2_9_144_1
  doi: 10.1016/j.pnpbp.2017.03.016
– ident: e_1_2_9_109_1
  doi: 10.1016/S0079-6123(07)67012-5
– ident: e_1_2_9_93_1
  doi: 10.1007/s00702-011-0741-3
– ident: e_1_2_9_25_1
  doi: 10.1016/j.psychres.2017.01.072
– ident: e_1_2_9_55_1
  doi: 10.1016/j.bbi.2017.11.013
– ident: e_1_2_9_135_1
  doi: 10.1016/j.atherosclerosis.2014.06.011
– ident: e_1_2_9_78_1
  doi: 10.1176/appi.ajp.157.8.1252
– ident: e_1_2_9_26_1
  doi: 10.1016/j.bbi.2016.09.012
– ident: e_1_2_9_138_1
  doi: 10.1016/j.yhbeh.2012.01.008
– volume: 156
  start-page: 585
  year: 1999
  ident: e_1_2_9_71_1
  article-title: Serial CSF corticotropin‐releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
  publication-title: Am. J. Psychiatry
  doi: 10.1176/ajp.156.4.585
– ident: e_1_2_9_117_1
  doi: 10.1016/j.neulet.2016.06.023
– ident: e_1_2_9_29_1
  doi: 10.1016/j.bbi.2016.10.014
– ident: e_1_2_9_121_1
  doi: 10.1002/da.22511
– ident: e_1_2_9_53_1
  doi: 10.1176/appi.ajp.2014.14020263
– ident: e_1_2_9_64_1
  doi: 10.1016/j.expneurol.2016.05.014
– ident: e_1_2_9_155_1
  doi: 10.1016/j.biopsych.2017.08.005
– ident: e_1_2_9_54_1
  doi: 10.1016/j.biopsych.2015.05.017
– ident: e_1_2_9_60_1
  doi: 10.1016/j.bbi.2017.10.025
– ident: e_1_2_9_15_1
  doi: 10.1016/j.jpsychires.2012.12.001
– ident: e_1_2_9_66_1
  doi: 10.1016/j.yfrne.2011.12.002
– ident: e_1_2_9_13_1
  doi: 10.1016/j.biopsych.2009.09.033
– ident: e_1_2_9_84_1
  doi: 10.1093/epirev/mxu011
– ident: e_1_2_9_6_1
  doi: 10.1016/S0005-7967(99)00123-0
– ident: e_1_2_9_31_1
  doi: 10.1016/j.bbi.2017.08.022
– ident: e_1_2_9_163_1
  doi: 10.1176/appi.ajp.2010.09091379
– ident: e_1_2_9_65_1
  doi: 10.1016/j.psyneuen.2014.10.022
– ident: e_1_2_9_77_1
  doi: 10.1016/S0006-3223(98)00276-5
– ident: e_1_2_9_83_1
  doi: 10.1037/hea0000593
– ident: e_1_2_9_146_1
  doi: 10.1159/000336811
– volume: 32
  start-page: 540
  year: 2011
  ident: e_1_2_9_115_1
  article-title: Interleukin‐6 and verbal memory in recurrent major depressive disorder
  publication-title: Neuro Endocrinol. Lett.
– ident: e_1_2_9_17_1
  doi: 10.1016/j.biopsych.2013.01.007
– ident: e_1_2_9_42_1
  doi: 10.4088/JCP.09m05106blu
– ident: e_1_2_9_86_1
  doi: 10.1016/j.bbi.2009.04.005
– ident: e_1_2_9_11_1
  doi: 10.1001/jama.2018.7028
– ident: e_1_2_9_21_1
  doi: 10.1073/pnas.0910794107
– ident: e_1_2_9_56_1
  doi: 10.1176/appi.ajp.158.3.484
– ident: e_1_2_9_96_1
  doi: 10.1016/j.biopsych.2010.04.028
– ident: e_1_2_9_44_1
  doi: 10.1034/j.1600-0447.2000.101001046.x
– ident: e_1_2_9_59_1
  doi: 10.1038/npp.2016.125
– ident: e_1_2_9_62_1
  doi: 10.1038/npp.2011.239
– ident: e_1_2_9_81_1
  doi: 10.1016/j.cell.2017.12.025
– ident: e_1_2_9_16_1
  doi: 10.1016/j.biopsych.2011.04.013
– ident: e_1_2_9_57_1
  doi: 10.1016/j.jpsychores.2012.10.013
– ident: e_1_2_9_49_1
  doi: 10.1111/acps.12217
– ident: e_1_2_9_10_1
  doi: 10.1016/j.biopsych.2014.06.015
– ident: e_1_2_9_75_1
  doi: 10.1016/j.tics.2011.04.004
– ident: e_1_2_9_139_1
  doi: 10.1097/HRP.0b013e3182a75b7d
– ident: e_1_2_9_141_1
  doi: 10.1016/j.diabet.2017.10.004
– ident: e_1_2_9_67_1
  doi: 10.1073/pnas.0438019100
– ident: e_1_2_9_89_1
  doi: 10.1038/s41583-018-0057-5
– ident: e_1_2_9_7_1
  doi: 10.1016/j.expneurol.2016.05.038
– ident: e_1_2_9_47_1
  doi: 10.1038/nri.2015.5
– ident: e_1_2_9_58_1
  doi: 10.1186/1471-244X-13-40
– ident: e_1_2_9_90_1
  doi: 10.1016/j.neuroscience.2015.05.018
– ident: e_1_2_9_2_1
  doi: 10.1017/S0033291717000708
– ident: e_1_2_9_147_1
  doi: 10.1016/j.psychres.2015.10.017
– ident: e_1_2_9_104_1
  doi: 10.1016/j.jad.2018.02.061
– ident: e_1_2_9_150_1
  doi: 10.1016/j.bbi.2015.06.012
– ident: e_1_2_9_80_1
  doi: 10.1001/archgenpsychiatry.2011.50
– volume: 82
  start-page: 264
  year: 2017
  ident: e_1_2_9_88_1
  article-title: Modulating effect of cytokines on mechanisms of synaptic plasticity in the brain
  publication-title: Biochemistry
– ident: e_1_2_9_85_1
  doi: 10.1089/jwh.2010.2675
– ident: e_1_2_9_95_1
  doi: 10.1016/S0006-3223(98)00246-7
– ident: e_1_2_9_73_1
  doi: 10.1016/S0303-7207(01)00722-5
– ident: e_1_2_9_24_1
  doi: 10.1016/j.jpsychires.2018.04.009
– ident: e_1_2_9_127_1
  doi: 10.1097/JCP.0000000000000180
– ident: e_1_2_9_125_1
  doi: 10.4088/JCP.11m07316
– ident: e_1_2_9_32_1
  doi: 10.1016/j.cccn.2003.12.019
– ident: e_1_2_9_116_1
  doi: 10.1016/j.schres.2017.04.015
– ident: e_1_2_9_20_1
  doi: 10.1001/jamapsychiatry.2016.0350
– ident: e_1_2_9_130_1
  doi: 10.4196/kjpp.2016.20.4.357
– ident: e_1_2_9_12_1
  doi: 10.1001/archinte.1987.00370090055011
– ident: e_1_2_9_36_1
  doi: 10.1016/j.biopsych.2003.11.018
– ident: e_1_2_9_14_1
  doi: 10.1097/PSY.0b013e3181907c1b
– ident: e_1_2_9_51_1
  doi: 10.1001/jamapsychiatry.2013.4374
– ident: e_1_2_9_161_1
  doi: 10.1016/j.nlm.2014.10.001
– ident: e_1_2_9_69_1
  doi: 10.1016/j.cpr.2012.02.002
– ident: e_1_2_9_79_1
  doi: 10.1001/jama.299.11.1291
– ident: e_1_2_9_142_1
  doi: 10.1152/ajpendo.90263.2008
– ident: e_1_2_9_105_1
  doi: 10.1037/a0038039
– ident: e_1_2_9_134_1
  doi: 10.1371/journal.pone.0111952
– ident: e_1_2_9_5_1
  doi: 10.1016/j.tics.2006.04.007
– ident: e_1_2_9_46_1
  doi: 10.1001/archgenpsychiatry.2010.71
– ident: e_1_2_9_120_1
  doi: 10.1192/bjp.bp.114.148551
– ident: e_1_2_9_126_1
  doi: 10.1111/j.1755-5949.2008.00071.x
– ident: e_1_2_9_39_1
  doi: 10.1016/j.cyto.2011.03.025
– ident: e_1_2_9_140_1
  doi: 10.3389/fphar.2018.00154
– ident: e_1_2_9_98_1
  doi: 10.1016/j.bbi.2016.08.011
– ident: e_1_2_9_35_1
  doi: 10.1002/ajmg.b.31212
– ident: e_1_2_9_87_1
  doi: 10.1038/nrn2297
– ident: e_1_2_9_99_1
  doi: 10.1016/j.psyneuen.2018.05.012
– ident: e_1_2_9_151_1
  doi: 10.1017/S0007114511005460
– ident: e_1_2_9_102_1
  doi: 10.1038/nrn.2016.155
– ident: e_1_2_9_3_1
  doi: 10.1176/appi.books.9780890425596
– ident: e_1_2_9_40_1
  doi: 10.1016/j.bbi.2013.01.081
– ident: e_1_2_9_63_1
  doi: 10.1016/j.expneurol.2016.07.024
– ident: e_1_2_9_136_1
  doi: 10.1038/npp.2017.162
– ident: e_1_2_9_19_1
  doi: 10.1016/S2215-0366(15)00309-0
– ident: e_1_2_9_114_1
  doi: 10.1007/s11011-014-9551-2
– ident: e_1_2_9_137_1
  doi: 10.1002/da.22596
– ident: e_1_2_9_91_1
  doi: 10.1186/1742-2094-9-275
– ident: e_1_2_9_18_1
  doi: 10.1038/mp.2011.165
– ident: e_1_2_9_156_1
  doi: 10.1002/jts.21848
– ident: e_1_2_9_107_1
  doi: 10.1001/archgenpsychiatry.2010.61
– ident: e_1_2_9_70_1
  doi: 10.1176/ajp.154.5.624
– ident: e_1_2_9_72_1
  doi: 10.1210/er.2002-0006
– ident: e_1_2_9_143_1
  doi: 10.1016/j.neuropharm.2012.10.002
– ident: e_1_2_9_149_1
  doi: 10.1097/JES.0b013e3181b7b3d9
– ident: e_1_2_9_103_1
  doi: 10.1523/JNEUROSCI.3112-10.2010
– ident: e_1_2_9_157_1
  doi: 10.4088/JCP.16m11364
– ident: e_1_2_9_160_1
  doi: 10.1016/j.concog.2011.02.003
– ident: e_1_2_9_118_1
  doi: 10.1111/j.1600-0404.2004.00286.x
– volume: 22
  start-page: 274
  year: 2010
  ident: e_1_2_9_123_1
  article-title: Effects of exogenous glucocorticoid on combat‐related PTSD symptoms
  publication-title: Ann. Clin. Psychiatry
– ident: e_1_2_9_92_1
  doi: 10.1038/nri3086
– ident: e_1_2_9_162_1
  doi: 10.1037/0033-2909.133.2.183
– ident: e_1_2_9_37_1
  doi: 10.1002/jts.20372
– ident: e_1_2_9_153_1
  doi: 10.1038/nn.4030
– ident: e_1_2_9_82_1
  doi: 10.1038/nature21363
– ident: e_1_2_9_111_1
  doi: 10.1016/j.neubiorev.2014.04.003
– ident: e_1_2_9_100_1
  doi: 10.1016/j.neuroimage.2011.10.090
– ident: e_1_2_9_158_1
  doi: 10.1176/appi.ajp.159.10.1675
– ident: e_1_2_9_106_1
  doi: 10.1016/j.jalz.2017.04.014
– ident: e_1_2_9_34_1
  doi: 10.1016/S1995-7645(12)60048-0
SSID ssj0003361
Score 2.6153557
SecondaryResourceType review_article
Snippet While post‐traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence...
While post-traumatic stress disorder (PTSD) is currently diagnosed based solely on classic psychological and behavioral symptoms, a growing body of evidence...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 143
SubjectTerms Arteriosclerosis
Autoimmune diseases
Biomarkers
Cardiovascular diseases
cytokine
Cytokines
Epidemiology
Inflammation
Metabolic syndrome
neuroinflammation
Pathogenesis
Pathophysiology
Post traumatic stress disorder
treatment
Title Inflammation and post‐traumatic stress disorder
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.12820
https://www.proquest.com/docview/2205148303
https://www.proquest.com/docview/2179412086
Volume 73
WOSCitedRecordID wos000464279200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  customDbUrl:
  eissn: 1440-1819
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003361
  issn: 1323-1316
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1440-1819
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003361
  issn: 1323-1316
  databaseCode: WIN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB5qK-LFt1itJYoHL5Emm0128STVYqGWIhV7C_sEQdLSpp79Cf5Gf4mbZBMVFARvCZmQZd6TnfkW4IwyIUxUkK5HBXYDzbhLJEUu94lEklAeqRxndhANh2QyoaMaXJazMAU-RPXDLbOM3F9nBs744ouRz0RyYZyrb-r1hm_0FtehcX3fexhUjhih0NZbyPWQF1pgoayRp3r5ezj6zDG_Zqp5qOlt_muRW7BhM0znqlCJbaipZAfW7uwe-i54_UQbNShGFh2WSGc2XaTvr2_pnC1zAFenGCBxpEXm3INx72bcvXXtwQmuCDDquH6keOBJzXxBBEGSYh6qKJSIKiMCXwdR3g7jEYWw4rqjTV4nMsuWKgpkiPahnkwTdQAOizzdUZown4UBlR0uQ4GxIijUWGKOmnBesi8WFlQ8O9viOS6LC8OBOOdAE04r0lmBpPETUauUQWyNaRFns8CmajPBtgkn1WNjBtneBkvUdGloMsfi-aZAM0vKJfL7R-JRd5hfHP6d9AjWTapEi56dFtTT-VIdw6p4SZ8W8zasRBPStvpn7h77ww_3Wt4Y
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB5KFfXiW6xWjeLBSyTJ5rELXqRYWmxDDwV7C5t9gCBpaVPP_gR_o7_E3c3DCgqCt0AmZJmd5-7MNwDXhDKmvAK3XcIC25c0tTEnyE49zBHHJI2EwZkdRHGMJxMyasBd1QtT4EPUB25aM4y91gquD6RXtHzGsltlXT2VsK_5KtDQgxue-nFthxEKy3QL2S5ywxJXSNfx1J9-90ZfIeZqoGo8TXfnf2vche0ywrTuC5HYg4bI9mFjWN6hH4Dbz6QSg6Jl0aIZt2bTRf7x9p7P6dIAuFpFA4nFS2TOQxh3H8adnl0OTrCZHyDH9iKR-i6X1GOYYcRJkIYiCjkiQm2BJ_3IlMO4WKBApNKRKq5jWrO5iHweoiNoZtNMHINFI1c6QmLq0dAn3El5yIJAYBTKgAcpasFNxb-ElaDierbFS1IlF4oDieFAC65q0lmBpPETUbvahKRUpkWie4FV1qacbQsu69dKDfTdBs3EdKlotGFxPZWgqSWZLfn9J8moE5uHk7-TXsBmbzwcJIN-_HgKWypsIkX9Thua-XwpzmCdvebPi_m5EcJPP8be4w
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB5KK8WLb7FaNYoHL5Emm8cueJHWYrGGIhV6C5t9gCBpaVPP_gR_o7_E3WQTKygI3gKZJcvsPLMz3wBcEMqY8grcdgjzbU_SxMacIDtxMUcckyQUOc7sMIwiPJmQUQ2uy16YAh-i-uGmNSO311rBxYzLFS2fsfRKWVdXJewNTw-RqUOj99h_GlaWGKHAJFzIdpATGGQhXclTLf7uj76CzNVQNfc1_c3_7XILNkyMad0UQrENNZHuQPPB3KLvgjNIpRKEomnRoim3ZtNF9vH2ns3pModwtYoWEosbbM49GPdvx90724xOsJnno47thiLxHC6pyzDDiBM_CUQYcESEOgRXemFeEONggXyRyI5UkR3Tus1F6PEA7UM9nabiACwaOrIjJKYuDTzCOwkPmO8LjALpcz9BLbgs-RczAyuup1u8xGV6oTgQ5xxowXlFOiuwNH4iapeHEBt1WsS6G1jlbcrdtuCseq0UQd9u0FRMl4pGmxbHVSma2lJ-JL9_JB51o_zh8O-kp9Ac9frxcBDdH8G6iptIUcDThno2X4pjWGOv2fNifmKk8BOMnN-M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation+and+post%E2%80%90traumatic+stress+disorder&rft.jtitle=Psychiatry+and+clinical+neurosciences&rft.au=Hori%2C+Hiroaki&rft.au=Kim%2C+Yoshiharu&rft.date=2019-04-01&rft.issn=1323-1316&rft.eissn=1440-1819&rft.volume=73&rft.issue=4&rft.spage=143&rft.epage=153&rft_id=info:doi/10.1111%2Fpcn.12820&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_pcn_12820
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-1316&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-1316&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-1316&client=summon